Literature DB >> 22696221

Protein kinase Cα phosphorylates a novel argininosuccinate synthase site at serine 328 during calcium-dependent stimulation of endothelial nitric-oxide synthase in vascular endothelial cells.

Ricci J Haines1, Karen D Corbin, Laura C Pendleton, Duane C Eichler.   

Abstract

Endothelial nitric-oxide synthase (eNOS) utilizes l-arginine as its principal substrate, converting it to l-citrulline and nitric oxide (NO). l-Citrulline is recycled to l-arginine by two enzymes, argininosuccinate synthase (AS) and argininosuccinate lyase, providing the substrate arginine for eNOS and NO production in endothelial cells. Together, these three enzymes, eNOS, AS, and argininosuccinate lyase, make up the citrulline-NO cycle. Although AS catalyzes the rate-limiting step in NO production, little is known about the regulation of AS in endothelial cells beyond the level of transcription. In this study, we showed that AS Ser-328 phosphorylation was coordinately regulated with eNOS Ser-1179 phosphorylation when bovine aortic endothelial cells were stimulated by either a calcium ionophore or thapsigargin to produce NO. Furthermore, using in vitro kinase assay, kinase inhibition studies, as well as protein kinase Cα (PKCα) knockdown experiments, we demonstrate that the calcium-dependent phosphorylation of AS Ser-328 is mediated by PKCα. Collectively, these findings suggest that phosphorylation of AS at Ser-328 is regulated in accordance with the calcium-dependent regulation of eNOS under conditions that promote NO production and are in keeping with the rate-limiting role of AS in the citrulline-NO cycle of vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696221      PMCID: PMC3406701          DOI: 10.1074/jbc.M112.378794

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase.

Authors:  B R Flam; P J Hartmann; M Harrell-Booth; L P Solomonson; D C Eichler
Journal:  Nitric Oxide       Date:  2001-04       Impact factor: 4.427

2.  Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.

Authors:  Koshi Imami; Naoyuki Sugiyama; Yutaka Kyono; Masaru Tomita; Yasushi Ishihama
Journal:  Anal Sci       Date:  2008-01       Impact factor: 2.081

3.  Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs.

Authors:  Michael A Collingwood; Scott D Rose; Lingyan Huang; Chris Hillier; Mohammad Amarzguioui; Merete T Wiiger; Harris S Soifer; John J Rossi; Mark A Behlke
Journal:  Oligonucleotides       Date:  2008-06

4.  PKCalpha activates eNOS and increases arterial blood flow in vivo.

Authors:  Chohreh Partovian; Zhenwu Zhuang; Karen Moodie; Michelle Lin; Noriyuki Ouchi; William C Sessa; Kenneth Walsh; Michael Simons
Journal:  Circ Res       Date:  2005-08-04       Impact factor: 17.367

5.  Endothelial argininosuccinate synthase mRNA 5'-untranslated region diversity. Infrastructure for tissue-specific expression.

Authors:  Laura C Pendleton; Bonnie L Goodwin; Brenda R Flam; Larry P Solomonson; Duane C Eichler
Journal:  J Biol Chem       Date:  2002-04-19       Impact factor: 5.157

6.  Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells.

Authors:  Bonnie L Goodwin; Larry P Solomonson; Duane C Eichler
Journal:  J Biol Chem       Date:  2004-02-16       Impact factor: 5.157

7.  Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells.

Authors:  Monica Montagnani; Lingamanaidu V Ravichandran; Hui Chen; Diana L Esposito; Michael J Quon
Journal:  Mol Endocrinol       Date:  2002-08

8.  A fluorometric assay for the measurement of nitrite in biological samples.

Authors:  T P Misko; R J Schilling; D Salvemini; W M Moore; M G Currie
Journal:  Anal Biochem       Date:  1993-10       Impact factor: 3.365

Review 9.  Life history of eNOS: partners and pathways.

Authors:  David M Dudzinski; Thomas Michel
Journal:  Cardiovasc Res       Date:  2007-04-03       Impact factor: 10.787

10.  Differential regulation of VEGF signaling by PKC-alpha and PKC-epsilon in endothelial cells.

Authors:  Christian Rask-Madsen; George L King
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-06       Impact factor: 8.311

View more
  5 in total

1.  Two functionally distinct pools of eNOS in endothelium are facilitated by myoendothelial junction lipid composition.

Authors:  Lauren A Biwer; Evan P Taddeo; Brandon M Kenwood; Kyle L Hoehn; Adam C Straub; Brant E Isakson
Journal:  Biochim Biophys Acta       Date:  2016-04-19

2.  Nitric oxide is the key mediator of death induced by fisetin in human acute monocytic leukemia cells.

Authors:  Dipankar Ash; Manikandan Subramanian; Avadhesha Surolia; Chandrima Shaha
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Nitric oxide production by glomerular podocytes.

Authors:  Oleg Palygin; Daria V Ilatovskaya; Vladislav Levchenko; Bradley T Endres; Aron M Geurts; Alexander Staruschenko
Journal:  Nitric Oxide       Date:  2017-11-08       Impact factor: 4.427

4.  Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents.

Authors:  W-B Tsai; Y Long; J-R Park; J T Chang; H Liu; J Rodriguez-Canales; N Savaraj; L G Feun; M A Davies; I I Wistuba; M T Kuo
Journal:  Oncogene       Date:  2015-06-22       Impact factor: 9.867

5.  Molecular characterization of argininosuccinate synthase and argininosuccinate lyase from the liver of the African lungfish Protopterus annectens, and their mRNA expression levels in the liver, kidney, brain and skeletal muscle during aestivation.

Authors:  You R Chng; Jasmine L Y Ong; Biyun Ching; Xiu L Chen; Wai P Wong; Shit F Chew; Yuen K Ip
Journal:  J Comp Physiol B       Date:  2014-07-18       Impact factor: 2.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.